US Patent Issued to Gen2 Neuroscience on Aug. 25 for "Tau epitope and binding molecules" (British Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,908, issued on Aug. 25, was assigned to Gen2 Neuroscience Ltd. (Manchester, Great Britain).

"Tau epitope and binding molecules" was invented by Frederick John Livesey (Manchester, Great Britain) and Clare Jones (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to isolated recombinant peptides comprising an epitope from human tau 2N4R. The invention also relates to use of such peptides to generate binding molecules, such as antibodies, specific for the tau epitope and to such peptides and antibodies for use in investigation, diagnosis and treatment of tauopathies, such as Alzheimer's disease."

The patent ...